2018
DOI: 10.37358/rc.18.3.6184
|View full text |Cite
|
Sign up to set email alerts
|

Formulation, Preparation, Physico-chimical Analysis, Microbiological Peculiarities and Therapeutic Challenges of Extractive Solution of Kombucha

Abstract: This paper aimed at the preparation and characterisation of an extractive solution of Kombucha. We have applied the method of water extraction of a species of yeast, Kombucha, grown and proliferated in the pharmaceutical technology laboratory of the Faculty of Pharmacy at Dunarea de Jos University of Galati. Samples of various sugar concentrations have been prepared, as well as samples subject to concentration, thus obtaining extracts of up to 80% concentration. The extract obtained was analysed chemically and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 0 publications
0
13
0
Order By: Relevance
“…Another promising indication is related to the usage of Piper Nigrum extract in the treatment of vitiligo, a cutaneous disease which causes color losses, occurring either by itself or associated with other autoimmune diseases, where the requirement of immunosuppressing, anti-inflammatory treatment could be complemented with natural extracts [36][37][38]. Experimentally, in the future, the natural extracts, either by themselves or combined, acting synergistically, could become useful in the prophylaxis of areas described as locus minoris resistentiae, or in the Wolf isomorphic phenomenon, which entails the occurrence of another dermatosis, different from the initial one, at the spot of cutaneous healing, a phenomenon which can also be understood as Koebner phenomenon type 5 [39][40][41]. Another possible domain can be represented by its use for ameliorating zoster or post-zoster pains, where capsaicin has a clearly quantified role owing to its capacity of inhibiting the P substance involved in the mechanism of zoster pain or that of other neuropathic pains or paresthesia.…”
Section: Resultsmentioning
confidence: 99%
“…Another promising indication is related to the usage of Piper Nigrum extract in the treatment of vitiligo, a cutaneous disease which causes color losses, occurring either by itself or associated with other autoimmune diseases, where the requirement of immunosuppressing, anti-inflammatory treatment could be complemented with natural extracts [36][37][38]. Experimentally, in the future, the natural extracts, either by themselves or combined, acting synergistically, could become useful in the prophylaxis of areas described as locus minoris resistentiae, or in the Wolf isomorphic phenomenon, which entails the occurrence of another dermatosis, different from the initial one, at the spot of cutaneous healing, a phenomenon which can also be understood as Koebner phenomenon type 5 [39][40][41]. Another possible domain can be represented by its use for ameliorating zoster or post-zoster pains, where capsaicin has a clearly quantified role owing to its capacity of inhibiting the P substance involved in the mechanism of zoster pain or that of other neuropathic pains or paresthesia.…”
Section: Resultsmentioning
confidence: 99%
“…It is useful, under specific circumstances, that new substances -perhaps plant derived products of limited adverse reaction potential -and non-aggressive alternative treatments to be investigated and used [18,37,46,56] for the prevention and management of chronic diseases. is well known today to use pharmaceuticals with retarding effect in the treatment of various diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Plant extracts with limited side effects potential should be used in selected cases, especially in Locus minorisresistentiae cutaneous areas [86][87][88][89]. Maybe a consensus on appropriate antiseptic solutions in dermatology would minimize possible medicolegal actions and our patients'suffering and risks.…”
Section: Discussionmentioning
confidence: 99%